Ligand validation:8GLH

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GLH_EDO_A_705	83%	89%	0.095	0.954	0.55	0.11	-	-	0	0	100%	1
8GLH_EDO_A_706	70%	84%	0.148	0.966	0.41	0.35	-	-	0	0	100%	1
8GLH_EDO_A_707	55%	79%	0.14	0.908	0.47	0.4	-	-	0	0	100%	1
8GLH_EDO_A_704	41%	94%	0.152	0.864	0.07	0.35	-	-	0	0	100%	1
5WKI_EDO_D_304	55%	80%	0.15	0.92	0.62	0.23	-	-	0	0	100%	1
8GLG_EDO_B_202	49%	53%	0.202	0.951	1.25	0.58	1	-	3	0	100%	1
5WL1_EDO_B_101	34%	12%	0.219	0.902	3.38	0.73	2	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.